Mahony Susan
SEC Form 4 insider trading activity
Mahony Susan has filed 1 SEC Form 4 filing (3 transaction rows) across 1 company, with disclosures dating back to 2026. 1 of those filings fall inside the rolling window. Most recent filing: Jun 11, 2026.
On the most recent filing, Mahony Susan is listed as Director at Axsome Therapeutics, Inc. Inside the rolling window, Mahony Susan reported no open-market purchases and 2 open-market sales totaling $145K in AXSM. The largest disclosed transaction in the window is a sale of 300 AXSM shares on Jun 10, 2026, worth $74K.
Companies traded
Other insiders at AXSM
Insider Buying
$0
reported purchases (SEC code P)
Insider Selling
$145K
reported sales (SEC code S)
Companies
1
in the rolling window
Frequently asked questions
How many SEC Form 4 filings has Mahony Susan made?
Mahony Susan has filed 1 SEC Form 4 filing (3 transaction rows) across 1 company since 2026.
Which companies does Mahony Susan trade?
Mahony Susan has filed SEC Form 4 disclosures for 1 company, including AXSM.
When was Mahony Susan's most recent SEC Form 4 filing?
Mahony Susan's most recent SEC Form 4 filing on Tracefour is dated Jun 11, 2026.
What is Mahony Susan's total buy and sell value in the current window?
Inside the rolling retention window, Mahony Susan bought $0 and sold $145K based on SEC Form 4 filings.
What was Mahony Susan's largest disclosed transaction?
The largest disclosed transaction in the current window is a sale of 300 AXSM shares on 2026-06-10, worth $74K, per SEC Form 4 filings.